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440 wileyonlinelibrary.com/journal/jrsmBackground: Multivariate meta‐analysis (MVMA) jointly synthesizes effects
for multiple correlated outcomes. The MVMA model is potentially more diffi-
cult and time‐consuming to apply than univariate models, so if its use makes
little difference to parameter estimates, it could be argued that it is redundant.
Methods: We assessed the applicability and impact of MVMA in Cochrane
Pregnancy and Childbirth (CPCB) systematic reviews. We applied MVMA to
CPCB reviews published between 2011 and 2013 with two or more binary out-
comes with at least three studies and compared findings with results of univar-
iate meta‐analyses. Univariate random effects meta‐analysis models were fitted
using restricted maximum likelihood estimation (REML).
Results: Eighty CPCB reviews were published. MVMA could not be applied
in 70 of these reviews. MVMA was not feasible in three of the remaining 10
reviews because the appropriate models failed to converge. Estimates from
MVMA agreed with those of univariate analyses in most of the other seven
reviews. Statistical significance changed in two reviews: In one, this was
due to a very small change in P value; in the other, the MVMA result for
one outcome suggested that previous univariate results may be vulnerable
to small‐study effects and that the certainty of clinical conclusions needs
consideration.
Conclusions: MVMA methods can be applied only in a minority of reviews of
interventions in pregnancy and childbirth and can be difficult to apply because
of missing correlations or lack of convergence. Nevertheless, clinical and/or
statistical conclusions from MVMA may occasionally differ from those from
univariate analyses.
KEYWORDS
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Meta‐analysis is an umbrella term for a suite of statistical
models for synthesizing parameter estimates (eg, inter-
vention effect estimates) from multiple studies. Each
model implies a set of assumptions, such as fixed or ran-
dom intervention effects.1 Often, a review has several out-
comes of interest (such as preterm delivery and neonatal
intensive care), and the effect estimates for these out-
comes may be correlated within primary studies, because
the same patients provide data towards them. Standard
univariate meta‐analysis (UVMA) methods do not
account for this correlation. In recognition of this, multi-
variate meta‐analysis (MVMA) models have been devel-
oped.2-4 Multivariate models have a number of potential
advantages over univariate counterparts. They facilitate
borrowing of strength across outcomes,5 which utilizes
more information and thereby potentially reduces uncer-
tainty and the impact of outcome reporting bias.6 They
also facilitate estimation of joint confidence and predic-
tion regions4,7 and allow appropriate confidence intervals
(CIs) to be calculated for functions of summary estimates
for multiple correlated outcomes.8
Empirical evidence of the impact of MVMA on results
and conclusions is limited. The MVMA model is potentially
more difficult and time‐consuming to apply than univariate
models, so if its use makes little difference to parameter
estimates, it could be argued that it is redundant. Trikalinos
et al9 reported results of a systematic investigation of the
difference in results across all reviews published by
Cochrane in the first quarter of 2012 for which the MVMA
model was readily applicable. They concluded that the
difference between univariate and multivariate results
was generally small and usually clinical conclusions did
not change. This finding concords with results from many
of the example datasets analyzed in methodological
papers.10,11 However, there are also many examples that
suggest the impact of MVMA can be large,5,6 especially
when there are (selectively) missing outcomes.12,13
The literature suggests that the difference between
univariate and multivariate results tends to be greater in
circumstances where the outcomes are highly correlated
and some studies do not report all outcomes (ie, there is
missing outcome data). Such situations often occur in
reviews performed by the Cochrane Pregnancy and
Childbirth (CPCB) Group, which routinely examines
multiple outcomes for both the mother and baby,14 mean-
ing that MVMA is more likely to have an impact in this
clinical area. In this paper, we use both univariate and
MVMA models to analyze aggregate data reported in
CPCB reviews. The purpose of the paper is threefold: first,
to identify how often the multivariate model is reason-
ably applicable in CPCB reviews; second, to determinehow often, and to what degree, the use of the multivariate
model leads to different statistical results and conclusions
than those obtained from the standard univariate model;
and third, to highlight any circumstances where reported
clinical conclusions in these reviews should potentially be
reconsidered in light of results from multivariate models.2 | METHODS
2.1 | Inclusion criteria
We screened the CPCB database15 to identify all reviews,
new or updated, published between January 2011 and Feb-
ruary 2013. Only reviews of interventions were considered.
If a review was published and updated during this period,
then we only considered the most recent version.
Each review was screened by M.J.P. for whether it
contained eligible outcomes. We considered an outcome
to be eligible if it was a binary primary outcome and
was reported by three or more studies. We considered a
review to be potentially suitable for MVMA if it had two
eligible maternal outcomes or two eligible neonatal out-
comes. Some reviews reported multiple intervention con-
trasts (eg, results comparing intervention A versus B and
B versus C). If more than one contrast would be eligible,
we considered only the first intervention contrast listed in
the review that fulfils these criteria. We then choose
either multiple maternal outcomes or multiple neonatal
outcomes on the basis of whichever was reported first.
Then, all binary primary outcomes of this type reported
by at least three studies were analyzed. Subgroup analysis
results were not included. We limited the analysis to pri-
mary outcomes to keep the dataset manageable and to
maintain focus on the most clinically relevant outcomes.
For each included outcome in each review, the outcome
description, intervention description, and the number of
events and number of patients at follow‐up (ie, a standard
two‐by‐two data table) in each arm were extracted. Data
extraction was performed by two statisticians independently
(M.J.P. and H.B.). The datasets were compared, and any dif-
ferences reconciled upon discussion with a third reviewer as
necessary. Data and outcomes where discussed with clinical
collaborators before analyses were undertaken.2.2 | Evidence synthesis methods
For each review that met the inclusion criteria, and for
each outcome identified, we derived the log odds ratio
(OR) estimates and their variances for each primary
study. If no events occurred in either arm, then the corre-
sponding outcome was treated as missing in that study.
This is in keeping with the usual approach to UVMA in
TABLE 1 Nested criterion for inclusion (number remaining
reports the number of reviews remaining after this criterion has
been assessed)
Criteria
Number of Reviews
Meeting Criteria
Most recent Cochrane Pregnancy
and Childbirth reviews
published between January 2011
and February 2013
80
Reviews contained at least three
studies in total
46
At least one outcome was reported
by three or more studies
31
At least one binary outcome was
reported by three or more studies
29
At least one binary primary
outcome was reported by three
or more studies
27
At least two (including 1+ primary)
binary outcomes, both maternal
or both neonatal, were reported by
three or more studies
18
At least two binary primary
outcomes, both maternal or both
neonatal, were reported by three
or more (not necessarily the
same) studies
10
MVMA models converged for at
least one pair of outcomes
7
Note. Twenty‐one studies included a contrast with at least two mother or two
neonatal binary (either primary or secondary) outcomes reported by three or
more (not necessarily the same) studies.
Abbreviation: MVMA, multivariate meta‐analysis.
442 PRICE ET AL.which studies with no events in either arm are given zero
weight.16 If this was the case for all outcomes (to be ana-
lyzed) in a study, then the study was excluded from the
analysis. If 0% or 100% of patients in just one arm had
events, then 0.5 was added to each cell in order to derive
the log OR and its standard error.16,17
We then applied, to each meta‐analysis dataset and to
each outcome separately, the standard univariate random
effects meta‐analysis model fitted using restricted maxi-
mum likelihood estimation (REML) (Appendix S1).1,18,19
The random effects model was used to account for hetero-
geneity, which was expected in most CPCB reviews.14
Meta‐analysis was performed on the log OR scale, and
the summary results were expressed as ORs, with 95% CIs.
If within‐study correlations between treatment effects
on outcomes were calculable, we attempted to fit a fully
hierarchical MVMA (here, bivariate) random effects
model (Appendix S2) to each pair of outcomes in each
review. As we only had access to summary level data
reported in journal articles, this was only possible if the
outcomes were structurally related, as follows. If the out-
comes were mutually exclusive, such as vaginal birth and
cesarean section, then within‐study correlations were
estimated using the method of Trikalinos and Olkin (see
their equation A3 in their appendix A).20 If one outcome
was a subset of the other (eg, cesarean section is a subset
of operative birth), the method shown by Trikalinos and
Olkin and derived by Wei and Higgins (see their equation
10)21,22 was used. In both cases, correlations in the treat-
ment effect estimates for each pair of outcomes are
induced because of the binary outcomes being negatively
correlated for mutually exclusive outcomes and positively
correlated for subset outcomes. In both papers, analytical
solutions for deriving these within‐study correlations are
given, which require the meta‐analyst to input the number
of participants and number of events in each trial arm for
each outcome. If neither of these two methods to calculate
within‐study correlations were applicable, we applied the
“Riley model,” the alternative MVMA model that does
not require within‐study correlations as it models an
amalgamation of the within‐study and between‐study cor-
relations (see Appendix S3).3 Finally, for each review con-
taining more than two eligible outcomes, an MVMA
model was fitted to all outcomes if possible, either using
the fully hierarchical approach or using the Riley model
(eg, a trivariate model was fitted if three outcomes were
eligible). All UVMA and MVMA models were estimated
in STATA version 14 using restricted maximum likelihood
via the mvmeta module.23,24 Standard errors for the sum-
mary estimates account for uncertainty in the between‐
study variance and covariance matrix estimates.23 Compu-
tational methods including criteria for lack of convergence
of the Riley model are outlined in Appendix S4.Results from UVMA and MVMAs were compared by
inspection of their summary estimates and CIs and in
particular the impact on the clinical and/or statistical
conclusions that would be drawn.3 | RESULTS
3.1 | Identification of reviews
Our search identified 80 CPCB reviews published
between January 2011 and February 2013. Of these, 27
reviews (34%) included at least one eligible outcome as
defined above, of which 10 included at least two primary
binary maternal or child outcomes for the same interven-
tion contrast, and hence were potentially suitable for
MVMA. A more detailed breakdown of the results at each
stage of the selection process is given in Table 1.
PRICE ET AL. 4433.2 | Results from analyzed reviews
Of the 10 eligible reviews, two, three, and four eligible
outcomes were identified in seven, two, and one of
the reviews, respectively. Within‐study correlations were
calculable in four of the reviews (two contained outcomes
that were mutually exclusive, and the other two
contained outcomes with a subset relationship). In the
other six reviews, only the Riley model could be consid-
ered: In three of these, it did not converge for any pair
of outcome using any of the methods described in
Appendix S4. Hence, multivariate results were only
available for seven of the 10 reviews. These seven reviews
are now discussed in turn, and results are presented in
Table 2:
Review 1. Cardiotocography versus intermittent auscul-
tation of fetal heart on admission to labor ward for
assessment of fetal wellbeing25
This review compares admission cardiotocography
versus intermittent auscultation for outcomes of (1) cesar-
ean section and (2) instrumental vaginal birth. These two
outcomes are mutually exclusive, and therefore, within‐
study correlations could be derived (range from lowest
to highest within‐study correlation −0.02 to −0.10). The
comparison includes four trials all reporting both out-
comes. The between‐study correlation is estimated to be
+1, and the summary intervention effect estimates and
CIs are almost identical for bivariate and univariate
models (Table 2). In the univariate model, the CI for
the intervention effect on cesarean section excludes
the null value (summary OR: 1.21; 95% CI, 1.00‐1.46)
whereas in the bivariate model, it includes it (summary
OR: 1.23; 95% CI, 0.99‐1.52). This slight change should
not affect the clinical conclusions for this outcome,
although statistical significance at the conventional 5%
level is affected, because of the P value in the MVMA
being >0.05.
Review 2. Cervical stitch (cerclage) for preventing pre-
term birth in singleton pregnancy (review)26
This review compares cerclage versus no cerclage for
outcomes of (1) all perinatal losses, (2) serious neonatal
morbidity, and (3) the composite outcome of perinatal
deaths and serious neonatal morbidity. Outcomes 1 and
2 are subsets of outcome 3, and therefore, using the
approach of Wei and Higgins,22 the within‐study correla-
tions could be derived between outcomes 1 and 3 and
outcomes 2 and 3 (range of within‐study correlations
from lowest to highest 0.64‐1.00). This allowed use of
the fully hierarchical model for these two analyses.However, outcomes 1 and 2 are not mutually exclusive,
nor is one a subset of the other, and so their within‐study
correlations were not obtainable. Therefore, the Riley
model was implemented for a bivariate analysis of out-
comes 1 and 2 and for a trivariate analysis of all three out-
comes, but for the latter, it did not converge.
Results from the three univariate and bivariate analy-
ses are shown in Table 2. Eight studies report outcome
1, and four of these report outcomes 2 and 3; thus, there
is a large proportion of missing data for outcomes 2 and 3.
The Riley model applied to outcomes 1 and 2 estimated
the overall correlation to be about −0.3, while the fully
hierarchical bivariate model gave between‐study correla-
tion estimates of +1 and −1 for outcomes 1 and 2 and
outcomes 1 and 3, respectively. Despite the very high cor-
relations and considerable missing data, the summary
meta‐analysis estimates were similar in univariate and
bivariate models, and statistical/clinical conclusions
remain the same. The main difference was seen in the
CI for the summary intervention effect for outcome 3,
which was somewhat narrower from the bivariate analy-
sis of outcomes 1 and 3 than the univariate analysis
(Table 2).
Review 3. Hypnosis for pain management during labor
and childbirth27
This review compares self‐hypnosis or hypnotherapy
versus control for outcomes of (1) use of pharmacological
pain relief/anesthesia and (2) spontaneous vaginal birth.
Six studies reported outcome 1, and four of these reported
outcome 2. There is no structural relationship between
these outcomes, so no within‐study correlations could
be derived. The Riley model converged, and the univari-
ate and bivariate estimates of the intervention effects
are shown in Table 2. The overall correlation was esti-
mated as −0.44. Meta‐analysis estimates and CIs are
fairly similar between the univariate and multivariate
models, and the latter would not alter the original statis-
tical or clinical conclusions from the univariate analyses
(Table 2).
Review 4. Intracutaneous or subcutaneous sterile water
injection compared with blinded controls for pain
management28
This review compares sterile water versus normal
saline for outcomes of (1) assisted vaginal birth and (2)
cesarean section. These outcomes are mutually exclusive,
so within‐study correlations were derivable (range −0.07
to −0.14). Seven studies reported outcome 2, of which
six reported outcome 1. The between‐study correlation
was estimated to be −1. The CIs for outcome 1 were
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446 PRICE ET AL.wider for the bivariate model than for the univariate
because the between‐study standard deviation was esti-
mated to be about twice as large. Estimates for outcome
2 were very similar in bivariate and univariate models,
although the between‐study standard deviation was zero
in the univariate model and 0.28 in the bivariate model.
Statistical and clinical conclusions would likely remain
unchanged between univariate and bivariate results
(Table 2).
Review 5. Tocolytics for preterm premature rupture of
membranes (review)29
This review compares tocolytic versus no tocolytic for
outcomes of (1) perinatal mortality and (2) neonatal
death. Outcome 2 is a subset of outcome 1, and so
within‐study correlations were derivable. The same seven
studies provide data on both outcomes. The number of
events for outcomes 2 and 1 in both arms is the same in
six of the seven trials generating within‐study correlations
of +1. The between‐study correlation is estimated to be
almost 1. Univariate and bivariate results are almost iden-
tical, and thus, statistical and clinical conclusions remain
unchanged (Table 2).
Review 6. Inhaled analgesia for pain management in
labor (review)30
This review compares nitric oxide versus flurane for
the outcomes of (1) satisfaction with pain relief, (2)
assisted vaginal birth, and (3) vomiting. Four studies
reported outcome 1, these and one further study reported
outcome 2, and two studies (one also reporting outcomes
1 and 2, the other just outcome 2) reported outcome 3.
There is no structural relationship between these out-
comes, so no within‐study correlations could be derived,
and therefore, the Riley model was fitted. The model con-
verged for the bivariate analyses of outcomes 1 and 2 and
outcomes 2 and 3. Univariate and bivariate analyses gave
very similar estimates and CIs for outcomes 1 and 2. For
outcome 3, the summary intervention effect estimate was
slightly higher and had a wider CI from the MVMA anal-
ysis. However, in all cases, clinical and statistical conclu-
sions would remain unchanged (Table 2).
Review 7. Interventions for preventing nausea and
vomiting in women undergoing regional anesthesia
for cesarean section31
The contrast used compares 5‐HT3 antagonists versus
placebo for outcomes of (1) intraoperative nausea, (2)
intraoperative vomiting, (3) postoperative nausea, and
(4) postoperative vomiting. Eight studies reported
PRICE ET AL. 447outcome 1 and seven of these outcome 2. Two of these
studies and two other studies reported outcome 3. The
same four studies reported outcome 4 along with a study
that had reported outcomes 1 and 2. There is no struc-
tural relationship between these outcomes, so no
within‐study correlations could be derived, and therefore,
the Riley model was fitted. All bivariate models con-
verged apart from the model including outcomes 1 and
3. Trivariate models including outcomes 1, 2, and 4, and
1, 3, and 4 also converged (Figure 1). The overall correla-
tion coefficients were generally low to moderate (range
−0.07 to 0.60) but high in the bivariate analysis between
outcomes 2 and 3 (0.93) and between outcomes 1 and 4
in the two trivariate analyses that converged (0.85, 0.98)
(0.52 in the bivariate model).
For outcomes 1 and 4, UVMA and all MVMA models
give similar estimates and CIs. However, the bivariate
model of outcomes 2 and 3 leads to different conclusions
about the evidence of effect for outcome 2. The estimated
MVMA summary OR for outcome 2 was 0.56 (95% CI,
0.25‐1.23). This OR is less extreme than the UVMA esti-
mated OR of 0.41 (95% CI, 0.17‐0.96). Viewed on the log
OR scale, the MVMA estimate is a little more preciseFIGURE 1 Univariate and multivariate meta‐analysis results for all
vomiting in women undergoing regional anesthesia for cesarean section
viewed at wileyonlinelibrary.com](standard error 0.81) than the UVMA estimate (standard
error 0.85). There is far less evidence to suggest a benefi-
cial intervention effect, with the CI substantially overlap-
ping 1.
This large shift triggered us to examine whether there
was evidence of small‐study effects for outcome 2 in the
UVMA.6 Outcome‐specific forest plots are shown in
Figure 2. A contour‐enhanced funnel plot was produced,
and this indeed revealed visual evidence of asymmetry for
outcome 2 (Figure 3): The smaller studies tended to give
more optimistic estimates of the intervention effect for
outcome 2 than the larger studies.
The MVMA model including outcomes 1 and 3 with
outcome 2 allowed inclusion of results from three further
studies (outcome 1 provides an additional study, and out-
come 3 provides an additional two studies) compared
with those in the UVMA of outcome 2. However, their
inclusion shifted the summary estimate for outcome 2
in opposite directions in the bivariate analyses. We there-
fore approximated a trivariate model of outcomes 1, 2,
and 3 to ascertain whether the univariate conclusions
about outcome 2 were robust or not. We fitted the Riley
model with correlations fixed to the values estimated inoutcomes from review 7: interventions for preventing nausea and
.31 CI, confidence interval; OR, odds ratio [Colour figure can be
FIGURE 2 Outcome‐specific forest plots for review 7: interventions
for preventing nausea and vomiting in women undergoing regional
anesthesia for cesarean section.31 A, Outcome 1: nausea‐intraoperative.
B, Outcome 2: vomiting‐intraoperative. C, Outcome 3: nausea‐
postoperative. CI, confidence interval. int means intervention; arm and
cont means control arm; Restricted Maximum Likelihood Estimation
(REML) full trial references can be found in reference 31 [Colour figure
can be viewed at wileyonlinelibrary.com]
FIGURE 3 Contour‐enhanced funnel plot for examining small‐
study effects in the univariate meta‐analysis for outcome 2
(vomiting‐intraoperative) in review 7: interventions for preventing
nausea and vomiting in women undergoing regional anesthesia for
cesarean section.31 OR, odds ratio [Colour figure can be viewed at
wileyonlinelibrary.com]
448 PRICE ET AL.the bivariate analyses (0.60 for outcomes 1 and 2; 0.93 for
outcomes 2 and 3; and 0 for outcomes 1 and 3 where the
bivariate analysis failed to converge). This gave a sum-
mary OR for outcome 2 of 0.55 (95% CI, 0.24‐1.26).We conclude that, because of the small‐study effects
and the impact of the correlation in MVMA when addi-
tionally incorporating outcomes 1 and especially 3, the
results are not robust to model choice. Therefore, results
from any model for this outcome should be treated with
caution.64 | DISCUSSION
In around 40% of the CPCB reviews screened, at least one
outcome was reported by three or more studies, and
MVMA of two or more primary maternal or child binary
outcomes was prima facie possible in 13%. If the criteria
were relaxed to analyze a primary and secondary out-
come, this increased to about 60%. We were able to fit
the MVMA model for at least one pair of outcomes in
seven of the 10 contrasts considered (one contrast from
each review). In four of these seven reviews, within‐study
correlations could be estimated for at least one pair of
outcomes. In the remaining reviews, we attempted to
fit the Riley model. This model has been shown, through
simulations, to produce approximately unbiased sum-
mary results, appropriate coverage, and increased preci-
sion compared with separate univariate analyses.3
However, it is an approximation and generally does not
perform as well as a fully hierarchical multivariate model
that includes within‐study correlations. Thus, if within‐
study correlations are available, the fully hierarchical
model is preferred. The model converged for at least
one pair of outcomes in three of the six remaining
reviews. Thus, convergence and estimation difficulties
are common for MVMA models.
PRICE ET AL. 449Overall, in five of the seven contrasts where an MVMA
could be fitted, statistical and clinical conclusions
remained unchanged. In the other two contrasts, there
was at least one outcome for which results would classi-
cally be labelled as “statistically significant” at the 5%
level under the univariate model but not under the mul-
tivariate model. The first was for the cesarean section out-
come in a comparison of cardiotocography versus
intermittent auscultation of fetal heart on admission to
labor ward for assessment of fetal wellbeing (review 1).
The univariate and multivariate estimates were almost
identical, but in this case, the CIs for the former crossed
the null value but did not for the latter. This says more
about the dangers of using the concept of statistical signif-
icance than it does the use of MVMA.
The other was for the intraoperative vomiting outcome
in review 7, comparing 5‐HT3 antagonists versus placebo
for preventing nausea and vomiting in women undergo-
ing regional anesthesia for cesarean section.31 In this
review, results from the univariate model suggested good
evidence of an improvement with intervention and that
this effect could be quite large. However, when correlated
data on the outcome of postoperative nausea were also
utilized in the MVMA, results from the Riley model
changed the conclusion about the effect on vomiting:
Now, there was very little evidence to conclude an effect
with the OR closer to 1 and wide CIs (although a strong
clinically important effect could not be ruled out). Assess-
ment of funnel plot asymmetry suggests the UVMA may
be vulnerable to small‐study effect bias in outcome 2, pos-
sibly because of publication and/or outcome reporting
bias. The MVMA partially corrects for bias introduced
by this mechanism, by utilizing additional studies via
the correlated outcome of postoperative nausea.6,32 How-
ever, conclusions about use of the treatment are unlikely
to change because of what is still a large observed central
estimate for the effect together with large improvements
for other outcomes.
Sometimes CIs were wider after MVMA, compared
with UVMA; this is because allowing for correlation
may lead to increases in the between‐study variance
estimates, which then lead to wider CIs. The associated
difficulties for borrowing of strength statistics when
estimated between‐study variances differ between univar-
iate and multivariate models have been discussed previ-
ously.33,34 In such situations, borrowing of strength still
occurs, but gain in precision of the pooled estimates is
not observed because of the larger variance estimates
and borrowing of strength statistics can be negative.
Our review has limitations. Our analysis only consid-
ered binary outcomes, and we could only fit a fully hier-
archical model when within‐study correlations could be
estimated directly from summary level data. However, anumber of other options could have been considered.
For example, a deterministic sensitivity analysis could
have been performed to examine the impact of different
plausible levels of correlation. Alternatively, we could
have attempted to obtain individual patient data allowing
within‐study correlations to be estimated for all out-
comes. Finally, the correlations could have been esti-
mated from external evidence and incorporated using a
Bayesian framework perhaps using individual patient
data from a subset of the trials. This could have been
aided by a reparameterization of the model in terms of
patient‐level correlations between outcomes (rather than
contrasts) as suggested by Wei and Higgins.22 In addition,
Bayesian methods with informative priors could have
been considered when the multivariate models (either
fully hierarchical or the overall correlation model) failed
to converge. However, we deliberately did not consider
these alternative methods as they are more complex to
implement and would be harder to implement routinely
within Cochrane.
A recent paper by Trikalinos et al covered a far
broader set of reviews9 and showed that MVMA usually
makes little difference. However, within their review,
there were examples where univariate and MVMAs led
to different summary results and conclusions. Having
established this, we sought to focus on the clinical area
of pregnancy and childbirth, to see if MVMA is more
consistently beneficial in an area where multiple and
correlated outcomes are routinely encountered. This
narrower focus also allowed us to consider the results of
each analysis in much more detail and discuss the results
with clinicians and epidemiologists who are experts in
the area.
MVMA allows joint inferences to be made for
intervention effects on multiple outcomes. It is worth
noting that even if multivariate and univariate summary
results are identical, subsequent postestimation analyses
(eg, economic models) that include intervention effect
estimates for more than one of these outcomes will be
incorrect if they do not allow for associations between
outcomes. This is because decision and economic
models require joint inferences about (functions of) the
multiple outcomes, such as the probability of both
outcomes 1 and 2 occurring, which requires their corre-
lation to be accounted for.7,35 So in such cases if multi-
variate synthesis is feasible, it will always be preferable
to multiple univariate syntheses.
Further methodological work is required to identify
scenarios where MVMA is likely to be of value. A recent
paper demonstrated how the amount of borrowing of
strength between outcomes can be summarized in a sin-
gle statistic.33 However, this requires the MVMA to have
been performed. A quick and easy method of determining
450 PRICE ET AL.whether MVMA is likely to be worthwhile before the
analysis is performed would be of great value for
researchers, many of whom are not statisticians (eg, in
Cochrane). To avoid the possibility of researchers only
reporting MVMA when the results move in a certain
direction, the criteria for undertaking an MVMA should
be prespecified in the analysis protocol. Work is needed
to consider which outcomes should be included in an
MVMA and to assess the sensitivity of results to this
choice where necessary. Finally, improved computation
methods are required to ensure MVMA models converge
more often. One avenue for investigation is the use of
Bayesian methods with informative priors for the hetero-
geneity variances.365 | CONCLUSIONS
MVMA is a useful method in principle, as the utilization
of additional information in MVMA will often lead to
stronger (more precise) inference and may even, on occa-
sion, change recommendations obtained by UVMA.
However, our review shows that it is currently not easy
to implement, may not converge, and often does not have
a big impact on intervention effect estimates or standard
errors. Our findings largely concord with a previous
empirical evaluation across all Cochrane clinical groups.9
MVMA should thus not be routinely used in Cochrane
meta‐analyses. However, it may be useful in certain situ-
ations, especially where there are missing data for some
outcomes or where postestimation modelling requires
intervention effect estimates for multiple correlated out-
comes. Because of new MVMA results identified by our
review, clinical conclusions about the effect of 5‐HT3
antagonists on intraoperative vomiting may need to be
more cautious than originally thought.AUTHORS CONTRIBUTION
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